Glycoengineered stem cell-derived extracellular vesicles for targeted therapy of acute kidney injury
- 4 February 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 318, 123165
Abstract
No abstract availableKeywords
Funding Information
- Korea Ministry of Science and ICT
- Korea Drug Development Fund
This publication has 55 references indexed in Scilit:
- Dopamine‐conjugated extracellular vesicles induce autophagy in Parkinson's diseaseJournal of Extracellular Vesicles, 2024
- Clinical Translation of Extracellular VesiclesAdvanced Healthcare Materials, 2023
- Cisplatin and AKI: an ongoing battle with new perspectives—a narrative reviewInternational Urology and Nephrology, 2022
- Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challengesAdvanced Drug Delivery Reviews, 2022
- Macrophages in the kidney in health, injury and repair2022
- Biodistribution of extracellular vesicles following administration into animals: A systematic reviewJournal of Extracellular Vesicles, 2021
- Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseasesJournal of Extracellular Vesicles, 2021
- Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivorsCancer Chemotherapy and Pharmacology, 2020
- Nanomicelle curcumin-induced DNA fragmentation in testicular tissue; Correlation between mitochondria dependent apoptosis and failed PCNA-related hemostasisActa Histochemica, 2017
- The CD44‐Mediated Uptake of Hyaluronic Acid‐Based Carriers in MacrophagesAdvanced Healthcare Materials, 2016